DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PAVA spray
PAVA spray
After Care of Those Who Have Been Exposed to PAVA (Captor) Spray Or Post Deployment of ‘Taser’ Device
Streptococcus Pneumoniae
'Response to the Director-General's Request
20 2200 Attachment 6
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl
CS and Pepper Spray and Taser Aftercare Guidance
Informe Acerca Del Uso De Gases Lacrimógenos Por Agentes Del Estado
February 2019 / Issue No
Xiv Congreso De La Sociedad Española Del Dolor Murcia, Del 1 Al 3 De Junio De 2017
Recommendations – Irritant Sprays: Clinical Effects and Management
Refining the Role of Less-Lethal Technologies: Critical Thinking, Communications, and Tactics Are Essential in Defusing Critical Incidents
Anxiety Disorder, Generalized
Download the Entire List In
Guiding Principles on Use of Force
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)Indol-5
Irritant Sprays: Clinical Effects and Management Recommendations for Healthcare Professionals (Forensic Physicians, Custody Nurses and Paramedics)
A Pain Relief Composition, Comprising a Trpv1 Selective Agonist, and Manufacture and Uses Thereof
(Cs) and Pava (Nonivamide) Sprays
Top View
The UK's Implementation of the UN Convention Against Torture and Other Cruel, Inhuman Or Degrading Treatment Or Punishment
Bradford Non-Lethal Weapons Research Project (BNLWRP)
Comparison Report on CS and PAVA Sprays
ACTUALIZACIÓN SOBRE EL USO DE LACRIMÓGENAS POR AGENTES DEL ESTADO CHILE, ENERO 2020 Texto Dr
Diphoterine® List of Tested Chemicals
TASER® – Fifteen Years On
Pava PROCEDURE
Mr Meirion James
Failure to Disclose Evidence 'Routine and Deliberate'
PAVA Spray a Prison Reform Trust Position Paper